Key result
The proposed classification of cardiomyopathies includes ion channelopathies as a primary category, reflecting advancements in molecular genetics and disease recognition.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
This AHA scientific statement provides a contemporary framework for classifying cardiomyopathies, notably incorporating molecular genetics and recognizing ion channelopathies as primary cardiomyopathies.
Classifications of heart muscle diseases have proved to be exceedingly complex and in many respects contradictory. Indeed, the precise language used to describe these diseases is profoundly important. A new contemporary and rigorous classification of cardiomyopathies (with definitions) is proposed here. This reference document affords an important framework and measure of clarity to this heterogeneous group of diseases. Of particular note, the present classification scheme recognizes the rapid evolution of molecular genetics in cardiology, as well as the introduction of several recently described diseases, and is unique in that it incorporates ion channelopathies as a primary cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Maron et al. (2006) studied this question. The proposed classification of cardiomyopathies includes ion channelopathies as a primary category, reflecting advancements in molecular genetics and disease recognition.
Synapse has enriched 10 related papers. Consider them for comparative context: